Core Laboratories N.V. (CLB) Stock Forecast
Data as of May 3, 2026Energy · Current price $14.04 (-4.16%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jul 15, 2024 | Luke Lemoine | Piper Sandler | $17.00 | +21.1% |
Top Analysts Covering CLB
CLB vs Sector & Market
| Metric | CLB | Energy Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.53 | 2.41 |
| Analyst Count | — | 10 | 18 |
| Target Upside | +78.1% | +33.3% | +14.9% |
| P/E Ratio | 21.60 | 30.83 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $122M | $123M | $125M | 1 |
| 2026-09-30 | $129M | $131M | $132M | 1 |
| 2026-12-31 | $130M | $131M | $133M | 1 |
| 2027-03-31 | $125M | $127M | $129M | 1 |
| 2027-06-30 | $130M | $131M | $133M | 1 |
| 2027-09-30 | $133M | $135M | $136M | 1 |
| 2027-12-31 | $133M | $134M | $136M | 1 |
| 2028-12-31 | $621M | $623M | $625M | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.12 | $0.12 | $0.12 | 1 |
| 2026-09-30 | $0.21 | $0.22 | $0.22 | 1 |
| 2026-12-31 | $0.21 | $0.21 | $0.21 | 1 |
| 2027-03-31 | $0.14 | $0.14 | $0.14 | 1 |
| 2027-06-30 | $0.20 | $0.21 | $0.21 | 1 |
| 2027-09-30 | $0.22 | $0.23 | $0.23 | 1 |
| 2027-12-31 | $0.22 | $0.23 | $0.23 | 1 |
| 2028-12-31 | $1.47 | $1.48 | $1.49 | 1 |
Frequently Asked Questions
What is the analyst consensus for CLB?
The consensus among 0 analysts covering Core Laboratories N.V. (CLB) is — with an average price target of $25.00.
What is the highest price target for CLB?
The highest price target for CLB is $17.00, set by Luke Lemoine at Piper Sandler on 2024-07-15.
What is the lowest price target for CLB?
The lowest price target for CLB is $17.00, set by Luke Lemoine at Piper Sandler on 2024-07-15.
How many analysts cover CLB?
0 analysts have issued ratings for Core Laboratories N.V. in the past 12 months.
Is CLB a buy or sell right now?
Based on 0 analyst ratings, CLB has a consensus rating of — with a +78.1% upside to the consensus target of $25.00.
What are the earnings estimates for CLB?
Analysts estimate CLB will report EPS of $0.12 for the period ending 2026-06-30, with revenue estimated at $123M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.